OMNICELL, INC. (OMCL)
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
NRX PHARMACEUTICALS, INC. (NRXP)
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
NEUROGENE INC. (NGNE)
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MONTE ROSA THERAPEUTICS, INC. (GLUE)
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IBIO, INC. (IBIO)
iBio to Participate in Upcoming Healthcare Investor Conferences
LIBERTY GLOBAL LTD. (LBTYA)
Liberty Global Schedules Investor Call for Second Quarter 2026 Results
PRAXIS PRECISION MEDICINES, INC. (PRAX)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ARHAUS, INC. (ARHS)
Arhaus Announces Participation in Jefferies Consumer Conference in Nantucket
SYNDAX PHARMACEUTICALS INC (SNDX)
Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data
DIANTHUS THERAPEUTICS, INC. /DE/ (DNTH)
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)